Insider Trading Alert - KFY, BCBP And MNK Traded By Insiders

Friday, Dec. 18, 2015, 77 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $24.26 to $4,955,373.00.

Highlighted Stocks Traded by Insiders:

Korn/Ferry International (KFY) - FREE Research Report

You Harry L., who is Director at Korn/Ferry International, sold 4,000 shares at $34.63 on Dec. 18, 2015. Following this transaction, the Director owned 9,400 shares meaning that the stake was reduced by 29.85% with the 4,000-share transaction.

The shares most recently traded at $33.08, down $1.55, or 4.7% since the insider transaction. Historical insider transactions for Korn/Ferry International go as follows:

  • 4-Week # shares sold: 4,000
  • 12-Week # shares sold: 4,000
  • 24-Week # shares sold: 4,000

The average volume for Korn/Ferry International has been 317,000 shares per day over the past 30 days. Korn/Ferry International has a market cap of $1.7 billion and is part of the services sector and diversified services industry. Shares are up 15.58% year-to-date as of the close of trading on Friday.

Korn/Ferry International, together with its subsidiaries, provides talent management solutions that help clients to design strategies and in the execution of building and attracting their talent worldwide. The stock currently has a dividend yield of 1.18%. The company has a P/E ratio of 19.2. Currently, there are 3 analysts who rate Korn/Ferry International a buy, no analysts rate it a sell, and 1 rates it a hold.

Exclusive Offer: Get the latest Stock Analysis on KFY - FREE

TheStreet Quant Ratings rates Korn/Ferry International as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels, solid stock price performance and notable return on equity. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full Korn/Ferry International Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

BCB Bancorp (BCBP) - FREE Research Report

Pasiechnik Alexander, who is Director at BCB Bancorp, sold 4,500 shares at $10.39 on Dec. 18, 2015. Following this transaction, the Director owned 93,949 shares meaning that the stake was reduced by 4.57% with the 4,500-share transaction.

The shares most recently traded at $10.64, up $0.25, or 2.31% since the insider transaction. Historical insider transactions for BCB Bancorp go as follows:

  • 4-Week # shares bought: 1,500
  • 12-Week # shares bought: 295,870
  • 24-Week # shares bought: 295,870

The average volume for BCB Bancorp has been 27,300 shares per day over the past 30 days. BCB Bancorp has a market cap of $113.7 million and is part of the financial sector and banking industry. Shares are down 9.29% year-to-date as of the close of trading on Friday.

BCB Bancorp, Inc. operates as the holding company for BCB Community Bank that provides banking products and services to businesses and individual in the United States. The stock currently has a dividend yield of 5.34%. The company has a P/E ratio of 13.1.

Exclusive Offer: Get the latest Stock Analysis on BCBP - FREE

TheStreet Quant Ratings rates BCB Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, increase in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and a generally disappointing performance in the stock itself. Get the full BCB Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Mallinckrodt (MNK) - FREE Research Report

Thompson Virgil D, who is Director at Mallinckrodt, sold 18,000 shares at $73.62 on Dec. 18, 2015. Following this transaction, the Director owned 50,896 shares meaning that the stake was reduced by 26.13% with the 18,000-share transaction.

The shares most recently traded at $70.94, down $2.68, or 3.78% since the insider transaction. Historical insider transactions for Mallinckrodt go as follows:

  • 4-Week # shares bought: 10,945
  • 4-Week # shares sold: 668
  • 12-Week # shares bought: 11,545
  • 12-Week # shares sold: 668
  • 24-Week # shares bought: 20,226
  • 24-Week # shares sold: 668

The average volume for Mallinckrodt has been 3.6 million shares per day over the past 30 days. Mallinckrodt has a market cap of $8.3 billion and is part of the health care sector and drugs industry. Shares are down 28.06% year-to-date as of the close of trading on Friday.

Mallinckrodt public limited company develops, manufactures, markets, and distributes specialty pharmaceutical and biopharmaceutical products, and nuclear imaging agents in the United States, Europe, the Middle East, Africa, and internationally. The company has a P/E ratio of 27.4. Currently, there are 10 analysts who rate Mallinckrodt a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MNK - FREE

TheStreet Quant Ratings rates Mallinckrodt as a sell. The company's weaknesses can be seen in multiple areas, such as its generally high debt management risk and generally disappointing historical performance in the stock itself. Get the full Mallinckrodt Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Stocks Fluctuate as Wall Street Monitors U.S.-China Trade Developments

Stocks Fluctuate as Wall Street Monitors U.S.-China Trade Developments

It's Another Disappointing Day of Action...So Far

It's Another Disappointing Day of Action...So Far

General Electric Can Be 'Taken Off the Critical List,' Says Jim Cramer

General Electric Can Be 'Taken Off the Critical List,' Says Jim Cramer

GE: A Bottom Is Not a Point In Time but a Process

GE: A Bottom Is Not a Point In Time but a Process

Apple Rises Despite Price Target Cut by Piper Jaffray

Apple Rises Despite Price Target Cut by Piper Jaffray